Evidence to Recommendations Clinical Considerations update, Vote: Novavax COVID-19 vaccine in adults ages 18 years and older

This video can also be viewed at
https://www.cdc.gov/vaccines/videos/low-res/ACIPJuly2022/ACIP-3_Novavax_Consideration-Vote-Adjourn_07-19-2022_LowRes.mp4